Atricure Overview
Valuation check: ATRC's P/E ratio is 273.8, above the Healthcare sector average of 25.3.
Get informed when a big investor buys or sells
+ Follow273.80
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for ATRC is 273.8. That is above the Healthcare sector average of 25.3. Investors often review this figure alongside Atricure's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ATRC currently prints 273.8 for P/E ratio, while the sector average sits near 25.3. That is roughly 982.4% above the sector mean. Large gaps often invite a closer look at Atricure's growth, margins, and balance sheet.
A P/E ratio of 273.8 for Atricure is not 'good' or 'bad' on its own. Compare it with the peer average (25.3) and with ATRC's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ATRC's P/E ratio (273.8), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Atricure's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
